Abstract
Treatment with a combination of 10 mg/kg i.p. methotrexate and 100 mg/kg i.p. nicotinamide inhibits the development of collagen II induced arthritis in male DBA/1 X B.10(4R) mice, as assessed by the arthritic index and whole blood chemiluminescence. The effect is much more pronounced than with either methotrexate or nicotinamide alone at the same concentrations. Determination of GOT and GPT levels in the blood revealed that the treatment causes no toxic side effects on the liver.
Similar content being viewed by others
REFERENCES
KrÖger, H., R. Miesel, W. Ehrlich, and M. Kurpisz. 1994. Arthritogenic mechanisms of deregulated poly-ADP-ribosylation in experimental models of arthritis. Z. Rheumatol. 53:(Suppl. 1), 59.
KrÖger, H., R. Miesel, A. Dietrich, M. Ohde, E. RaijnavÖlgyi, and H. Ockenfels. 1996. Synergistic effects of thalidomide and poly(ADP-ribose)polymerase inhibition on collagen type II induced arthritis in mice. Inflammation 20:203–215.
Miesel, R., M. Kurpisz, and H. KrÖger. 1995. Modulation of inflammatory arthritis by inhibition of poly(ADP-ribose)polymerase. Inflammation 19:379–387.
KrÖger, H., and W. Ehrlich. 1994. The influence of tryptophan and nicotinamide on acetaminophenon hepatoxicity in mice potentiated by ethanol and on adjuvans arthritis in rats. In L-Tryptophan: Current Prospects in Medicine. W. Kochen, H. Steinhart, editors, de Gruyter, Berlin, 171–178.
Ehrlich, W., H. Huser, and H. KrÖger. 1995. Induction and activation of procollagenase in rabbit synovial fibroblasts after treatment with active oxygen released by xanthine oxidase. Rheumatol. Int. 15:131–136.
Ehrlich, W., H. Huser, and H. KrÖger. 1995. Inhibition of the induction of collagenase by interleukin-1B in cultured rabbit synovial fibroblasts with the poly(ADP-ribose)polymerase inhibitor 3-aminobenzamide. Rheumatol. Int. 15:131–136.
KrÖger, H., J. Klosa, R. GrÄtz, A. Dietrich, W. Ehrlich, and A. Wild. 1996. The therapeutic effect of a combination of cofpropamine, a caffeine derivative and, cyclophosphamide on the development of adjuvant arthritis in rats and collagen arthritis in mice. Gen. Pharmacol. 27:1215–1218.
Pincus, T., S. B. Marum, and C. F. Callahan. 1992. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices. II Second line drugs and prednisone. J. Rheumatol. 19:1885–1894.
Cash, J. M., and J. H. Knippel. 1994. Second-line drug therapy for rheumatoid arthritis. N. Engl. J. Med. 330:1368–1374.
Guhner, R., S. August, and V. Ginsberg. 1951. Therapeutic suppression of tissue reactivity. II. Effect of aminopterine in rheumatoid arthritis and psoriasis. Am. J. Med. Sci. 221:176–182.
Krall, P. L., D. J. Mazanek, and W. S. Wilke. 1989. Methotrexate for corticoid-resistant polymyalgia rheumatica and giant cell arthritis. Cleve. Clin. J. Med. 56:253–257.
Rothenberg, R. J., F. M. Graciano, J. T. Grandone et al. 1989. The use of methotrexate in steroid-resistant systemic lupus erythematosus. Arthritis Rheum. 31:612–615.
Scully, C. J., C. J. Anderson, and G. L. O. Cannon. 1991. Longterm methotrexate therapy for rheumatoid arthritis. Semin. Arthritis Rheum. 20:317–331.
Kremer, J. M., and C. T. phelps. 1992. Longterm prospective study of the use of methotrexate in the treatment of rheumatoidx arthritis, update after a mean of 90 months. Arthritis Rheum. 35:138–145.
Kremer, J. M., G. S. Alarcon, R. W. Lightfoot Jr., C. F. Wilkens, D. E. Furst, H. J. Williams, P. B. Dent, and M. E. Weinblatt. 1994. Methotrexate for rheumatoid arthritis, suggested guidelines for monitoring liver toxicity. Arthritis Rheum. 37:316–328.
Carrol, G. J., R. Tomas, C. C. Phatouros, M. H. Atchison, A. L. Leslie, N. J. Cook, and I. D'Souza. 1994. Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J. Rheumatol. 21:51–54.
Milunski, A., J. W. Greaf, and M. F. Gayner. 1968. Methotrexate-induced congenital malformations. J. Pediatr. 72:790–795.
Bergmeyer, H. H. 1974. Methoden der enzymatischen Analyse, p. 491, Verlag Chemie, Weinheim.
H. KrÖger, W. Ehrlich, M. Klewer, R. GrÄtz, A. Dietrich, and R. Miesel. 1996. The influence of antagonists of poly(ADP-ribose)metabolism on acetaminophen hepatotoxicity. Gen. Pharm. 27:167–170.
KrÖger, H., M. Klewer, R. GrÄtz, A. Dietrich, W. Ehrlich, S. Altrichter, M. Kurpisz, and R. Miesel. 1996. Influence of diet free of NAD-Precursers on acetaminophen hepatotoxicity in mice. Gen. Pharm. 27:79–82.
Graf, U., H. J. Henning, K. Stange, und P. Th. Wilrich. 1987. In Formlen und Tabellen der angewandten mathematischen Statistik. Springer-Verlag, Berlin-Heidelberg-New York.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kröger, H., Hauschild, A., Ohde, M. et al. Enhancement of the Effect of Methotrexate on Collagen II Induced Arthritis in Mice by Nicotinamide. Inflammation 22, 277–285 (1998). https://doi.org/10.1023/A:1022348132132
Issue Date:
DOI: https://doi.org/10.1023/A:1022348132132